To me, the San Francisco streets seemed deserted. To my self-driving car, they were full of hazards. In mid-March, just as the coronavirus outbreak started to change the world as we knew it, I took a ride in an autonomous vehicle through the narrow and winding, topsy-turvy streets of downtown San Francisco -- from the hairpin turns of Lombard Street to the steep hills surrounding Coit Tower and the famed Embarcadero waterfront. Even with tens of thousands of workers staying put as the first work-from-home orders hit, in the back of a Toyota Highlander piloted by autonomous vehicle start-up Zoox, I started to become hyper-aware of the circus of hazards robocars encounter on a daily basis. There was a cyclist or skateboarder in the blind spot.

Boeing Australia has presented the country's Air Force with a prototype of a jet-powered drone that they hope will one day fly alongside manned warplanes while bringing artificial intelligence to the battlefield.https://cnn.it/2ST7Qhp

With an unavoidable recession in the cards, what can we expect in the coming months? How quickly can markets, societies and small businesses recover? The past decade was successful overall, showcasing phenomenal four-times S&P growth and close to seven-times Nasdaq growth. After crashing in March 2009, both rose in the face of adversity by mid-February 2020. But that all changed by March 2020.

Geneia's non-linear model accurately identifies patients' future costs at high-cost thresholds such as between $50,000 and $99,999 in health costs in the next 12 months. Our model requires less data to train, utilizes novel data sources and outperforms well-known commercial tools. The GDI Lab is working to determine whose cost can be most affected or, in other words, the impactable patients who are most likely to benefit from care management intervention. We know targeting only the riskiest patients means lost opportunities. For example, the chart below compares a risky patient with an impactable one, and shows the associated savings opportunity. High-cost and high-needs are not the same as highly impactable. As C. Annette DuBard, MD, MPH and Carlos T. Jackson, PhD, discussed in their paper, Active Redesign of a Medicaid Care Management Strategy for Greater Return on Investment: Predicting Impactability, "Targeting strategies that seek to identify patients based on high current or predicted costs or utilization are likely to identify large numbers of individuals whose healthcare needs will not be meaningfully altered by care management intervention." Their research with Community Care of North Carolina's Medicaid patient led to the creation of an impactability score.

Is Artificial Intelligence (AI) here to stay? Will it bring a complete end to human interventions? Such questions set the context in which people generally think about AI. Whether they have come to a conclusion or not is a different matter altogether. But it can't be denied that today, AI is integral to various organizations' growth.

Even before the COVID-19 pandemic had spread across the globe, Artificial Intelligence (AI) had already begun to redraw the landscape of medical science. Indeed, the remarkable predictive power of AI has seen it take centre stage in the unprecedented fight against COVID-19. In this, the second of our articles relating to COVID-19, we look at innovation in the COVID-19 crisis focusing on this use of AI. AI is now being employed in a multitude of applications in relation to the pandemic, including vaccine development, patient diagnosis, and tracking real time transmission of COVID in the community.It is being used to predict how the virus may spread during lockdown easing and even predict wider behavioural patterns, such as panic buying. Unsurprisingly, AI platforms are being widely applied to the identification of COVID-19 therapeutics. The novel coronavirus has demanded a re-examination of our therapeutic toolbox for drugs that may be repurposed to treat the infection.

No technology is universally applicable. There is no single technology that can act as a master key to unlock all potential systems solutions. The attitude towards modern artificial intelligence (AI) is the subject of a debate among policymakers in the European Union (EU) across its member states. On 19 February 2020, the European Commission launched a public consultation on AI. Contrary to popular thought, modern AI does not in and of itself constitute an excellence (and competence) or trust (and security) problem, nor an ethical and regulatory problem.

Starship, the Estonian robot delivery company, has never been busier. Since the UK brought in social distancing measures that limited people's ability to go shopping, the number of deliveries made by its fleet of autonomous robots has rocketed. "Our robots have gone from a convenience to a necessity for a lot of people, and that is a big mental shift." "We are expanding into new neighbourhoods every week. Prior to the Covid-19 crisis, we'd expand into a new area monthly, but now we are constantly getting enquiries asking if we can deliver in new places," says Henry Harris-Burland, vice president of marketing at Starship.

The pandemic caused by COVID-19 is the first global public health crisis of the 21st century. And today, multiple AI-powered projects based on data science, 'machine learning' or'big data', are being used across a broad range of fields to predict, explain and manage the different scenarios caused by the health crisis. AI is being used to support and help those making decisions. "No decisions, at any step, are fully and exclusive delegated on the algorithm," explains Nuria Oliver, data scientist, who holds a Ph.D. from the Media Lab at Massachusetts Institute of Technology (MIT) and is the Regional Government of Valencia's commissioner on AI matters. In the context of the pandemic, AI is being applied and delivering results in three fields: in virus research and the development of drugs and vaccines; in the management of services and resources at healthcare centers; and in the analysis of data to support public policy decisions aimed at managing the crisis, such as the confinement measures.

How on earth did they get their driver's license? This is something we've all said about some maniac on the road. Despite strict laws, there are still plenty of people not concentrating on the road. Thankfully, the future of safer driving is upon us. The eventuality is that driving could become a thing of the past.